Last reviewed · How we verify

NCT05747040: PAINLESS

Pain in Neurorehabilitation Through Wearable Devices: an Exploratory Study

Status unknown NA Last updated 28 February 2023
What this trial tests

NA trial testing monitoring in Pain in 15 participants. Status unknown.

Timeline
1 February 2023
Primary endpoint
1 October 2023
1 October 2023

Quick facts

Lead sponsorAzienda Usl di Bologna
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment15
Start date1 February 2023
Primary completion1 October 2023
Estimated completion1 October 2023
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Azienda Usl di Bologna — full company profile →

Who can join

Adults 18 to 75, any sex, with Pain or Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This exploratory interventional study aims at exploring the feasibility of using physiological signals recorded through wearable devices, together with artificial intelligence techniques, to assess pain automatically and objectively. Automatic methods to assess presence/absence of pain, discern nociceptive from neuropathic pain, and estimate the intensity of pain will be trained an tested on a population of multiple sclerosis patients undergoing neurorehabilitation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Feasibility interventional study investigating PAIN in neurorehabilitation through wearabLE SensorS (PAINLESS): a study protocol.
    Moscato S, Orlandi S, Di Gregorio F, Lullini G, et al · · 2023 · cited 2× · PMID 37993169 · DOI 10.1136/bmjopen-2023-073534

Verify or expand the search:

Other trials of monitoring

Trials testing the same drug.

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Azienda Usl di Bologna trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05747040.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing